Citation Impact
Citing Papers
Genes, molecules and patients—Emerging topics to guide clinical pain research
2013
Hallmarks of Cancer: The Next Generation
2011 Standout
Combination of CTLA-4 and PD-1 blockers for treatment of cancer
2019
Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer
2015
Neoadjuvant Chemotherapy Use in Breast Cancer is Greatest in Excellent Responders: Triple-Negative and HER2+ Subtypes
2018
Zoledronic acid impairs myeloid differentiation to tumour-associated macrophages in mesothelioma
2010
Highly specific in vivo gene delivery for p53-mediated apoptosis and genetic photodynamic therapies of tumour
2015
Breast cancer statistics, 2019
2019 Standout
Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size
2011 Standout
Breast cancer
2016 Standout
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Signal integration by JNK and p38 MAPK pathways in cancer development
2009 Standout
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
2012 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
AP-1: a double-edged sword in tumorigenesis
2003 Standout
Smoldering and polarized inflammation in the initiation and promotion of malignant disease
2005 Standout
Cancer drug resistance: an evolving paradigm
2013 Standout
Organometallic chemistry, biology and medicine: ruthenium arene anticancer complexes
2005 Standout
The biology and function of fibroblasts in cancer
2016 Standout
Coordinated regulation of myeloid cells by tumours
2012 Standout
Hepatocellular carcinoma
2021 Standout
Curcumin as “Curecumin”: From kitchen to clinic
2007 Standout
The immune contexture in cancer prognosis and treatment
2017 Standout
Angiogenesis: an organizing principle for drug discovery?
2007 Standout
Application of Molecular Profiling in Clinical Trials for Advanced Metastatic Cancers
2015
Pharmacology of bisphosphonates
2011
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Molecular mechanisms of cisplatin resistance
2011 Standout
Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis
2014 Standout
Ectopic Expression of Nonliganded Retinoic Acid Receptor β Abrogates AP-1 Activity by Selective Degradation of c-Jun in Cervical Carcinoma Cells
2004 StandoutNobel
Alzheimer's disease, enzyme targets and drug discovery struggles: From natural products to drug prototypes
2014
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
The use of combinations of monoclonal antibodies in clinical oncology
2015
Extracellular matrix structure
2015 Standout
In vivo biodistribution of platinum-based drugs encapsulated into multi-walled carbon nanotubes
2014
Oxaliplatin for the treatment of cisplatin-resistant cancer: A systematic review
2007
Bladder cancer
2016 Standout
Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
2018 Standout
Immune checkpoint inhibitors in advanced renal cell carcinoma: experience to date and future directions
2017
The promise of retinoids to fight against cancer
2001
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
The role of tumour–stromal interactions in modifying drug response: challenges and opportunities
2013
Paradoxical roles of the immune system during cancer development
2006 Standout
Strategies and challenges for the next generation of antibody–drug conjugates
2017 Standout
Macrophage plasticity and polarization: in vivo veritas
2012 Standout
First-in-human multicenter phase I study of BMS-936561 (MDX-1203), an antibody-drug conjugate targeting CD70
2015
Comprehensive analysis of kinase inhibitor selectivity
2011 Standout
Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets
2008
The angiogenic switch in carcinogenesis
2009
Clonal evolution in cancer
2012 StandoutNature
Optimization of (1,2-diamino-cyclohexane)platinum(II)-loaded polymeric micelles directed to improved tumor targeting and enhanced antitumor activity
2007
Nanoparticle delivery of photosensitive Pt(IV) drugs for circumventing cisplatin cellular pathway and on-demand drug release
2014
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
An amino-bisphosphonate targets MMP-9–expressing macrophages and angiogenesis to impair cervical carcinogenesis
2004
Novel approaches to target the microenvironment of bone metastasis
2021
Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
2006 Standout
AZD9291 in EGFR Inhibitor–Resistant Non–Small-Cell Lung Cancer
2015 Standout
Cancer genomics: from discovery science to personalized medicine
2011
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Bioavailability of Curcumin: Problems and Promises
2007 Standout
Targeting the Tumor Microenvironment: From Understanding Pathways to Effective Clinical Trials
2013
An amino-bisphosphonate targets MMP-9–expressing macrophages and angiogenesis to impair cervical carcinogenesis
2004
The Lymphatic System: Integral Roles in Immunity
2016 Standout
Bright Side of Lignin Depolymerization: Toward New Platform Chemicals
2018 Standout
Distinct Role of Macrophages in Different Tumor Microenvironments
2006 Standout
Chemotherapy for advanced gastric cancer
2017 Standout
Breast Cancer Treatment
2019 Standout
Construction and Application of a Rh–Pt DNA Metalloinsertor Conjugate
2014
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Clinical features and pathophysiological basis of sensory neuronopathies (ganglionopathies)
2004
Strategies for the Optimization of Natural Leads to Anticancer Drugs or Drug Candidates
2015
Neuropathic Pain: From Mechanisms to Treatment
2020 Standout
Cancer treatment and survivorship statistics, 2016
2016 Standout
The Next Decade of Immune Checkpoint Therapy
2021 Nobel
Methylated metabolites of arsenic trioxide are more potent than arsenic trioxide as apoptotic but not differentiation inducers in leukemia and lymphoma cells.
2003
Plant Secondary Metabolites as Anticancer Agents: Successes in Clinical Trials and Therapeutic Application
2018 Standout
Historical perspectives on the clinical development of bisphosphonates in the treatment of bone diseases.
2007
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Overcoming Tamoxifen Resistance of Human Breast Cancer by Targeted Gene Silencing Using Multifunctional pRNA Nanoparticles
2016
Liposomal curcumin with and without oxaliplatin: effects on cell growth, apoptosis, and angiogenesis in colorectal cancer
2007
American Society of Clinical Oncology Perspective: Raising the Bar for Clinical Trials by Defining Clinically Meaningful Outcomes
2014
Angiogenic Role of LYVE-1–Positive Macrophages in Adipose Tissue
2007
Functional Interrogation of the Kinome Using Nucleotide Acyl Phosphates
2006
The Role of Angiogenesis in Cancer Treatment
2017
Cancer treatment and survivorship statistics, 2014
2014 Standout
Works of Amna Ibrahim being referenced
Approval summary for zoledronic acid for treatment of multiple myeloma and cancer bone metastases.
2003
CDK4/6 inhibitor treatment for patients with hormone receptor-positive, HER2-negative, advanced or metastatic breast cancer: a US Food and Drug Administration pooled analysis
2019
First FDA Approval of Neoadjuvant Therapy for Breast Cancer: Pertuzumab for the Treatment of Patients with HER2-Positive Breast Cancer
2014
First FDA Approval of Dual Anti-HER2 Regimen: Pertuzumab in Combination with Trastuzumab and Docetaxel for HER2-Positive Metastatic Breast Cancer
2013
Exposure–Response Relationship of T-DM1: Insight Into Dose Optimization for Patients With HER2-Positive Metastatic Breast Cancer
2014
The Role of SN‐38 Exposure, UGT1A1*28 Polymorphism, and Baseline Bilirubin Level in Predicting Severe Irinotecan Toxicity
2006
Abiraterone Acetate in Combination with Prednisone for the Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer: U.S. Food and Drug Administration Drug Approval Summary
2013
FDA analysis of treatment beyond disease progression disease (PD) in patients with metastatic renal cell carcinoma (mRCC) treated with nivolumab vs. everolimus.
2016
Radium Ra 223 Dichloride Injection: U.S. Food and Drug Administration Drug Approval Summary
2013
Development of Systemic and Topical Drugs to Treat Non-muscle Invasive Bladder Cancer
2015
A population pharmacokinetic model for zoledronic acid (ZOMETA) in patients with bone metastases
2003
U.S. Food and Drug Administration Drug Approval Summaries: Imatinib Mesylate, Mesna Tablets, and Zoledronic Acid
2002
Analysis of the Association Between Adverse Events and Outcome in Patients Receiving a Programmed Death Protein 1 or Programmed Death Ligand 1 Antibody
2019
Drug Approval Summaries: Arsenic Trioxide, Tamoxifen Citrate, Anastrazole, Paclitaxel, Bexarotene
2001
FDA Drug Approval Summaries: Oxaliplatin
2004
FDA Approval Summary: Temsirolimus as Treatment for Advanced Renal Cell Carcinoma
2010